G Clément1, J Benhattar. 1. Institut de Pathologie, Centre Hospitalier Universitaire Vaudois, Bugnon 25, 1011 Lausanne, Switzerland.
Abstract
BACKGROUND: There is increasing interest in DNA methylation and in its implication in transcriptional gene silencing, a phenomenon commonly seen in human cancer. AIMS: To develop a new method that would allow quantitative DNA methylation analysis in a large range of clinical samples, independently of the processing protocol. METHODS: A methylation sensitive dot blot assay (MS-DBA) was developed, which is quantitative and combines bisulfite modification, PCR amplification using primers without CpG sites, and dot blot analysis with two probes specific for methylated and unmethylated DNA. RESULTS: The established method was used to study methylation of the hTERT, APC, and p16 promoter regions in microdissected, formalin fixed and paraffin wax embedded tissues. CONCLUSIONS: MS-DBA is a sensitive, specific, and quantitative approach to analyse DNA methylation in a variety of frozen or fixed tissues. Moreover, MS-DBA is rapid, easy to perform, and permits the screening of a large panel of samples in one experiment. Thus, MS-DBA can facilitate the routine analysis of DNA methylation in all types of clinical samples.
BACKGROUND: There is increasing interest in DNA methylation and in its implication in transcriptional gene silencing, a phenomenon commonly seen in humancancer. AIMS: To develop a new method that would allow quantitative DNA methylation analysis in a large range of clinical samples, independently of the processing protocol. METHODS: A methylation sensitive dot blot assay (MS-DBA) was developed, which is quantitative and combines bisulfite modification, PCR amplification using primers without CpG sites, and dot blot analysis with two probes specific for methylated and unmethylated DNA. RESULTS: The established method was used to study methylation of the hTERT, APC, and p16 promoter regions in microdissected, formalin fixed and paraffin wax embedded tissues. CONCLUSIONS: MS-DBA is a sensitive, specific, and quantitative approach to analyse DNA methylation in a variety of frozen or fixed tissues. Moreover, MS-DBA is rapid, easy to perform, and permits the screening of a large panel of samples in one experiment. Thus, MS-DBA can facilitate the routine analysis of DNA methylation in all types of clinical samples.
Authors: Robert P Balog; Y Emi Ponce de Souza; Hue M Tang; Gina M DeMasellis; Boning Gao; Adrian Avila; Desmond J Gaban; David Mittelman; John D Minna; Kevin J Luebke; Harold R Garner Journal: Anal Biochem Date: 2002-10-15 Impact factor: 3.365
Authors: C A Eads; K D Danenberg; K Kawakami; L B Saltz; C Blake; D Shibata; P V Danenberg; P W Laird Journal: Nucleic Acids Res Date: 2000-04-15 Impact factor: 16.971
Authors: Vo Thi Thuong Lan; Nguyen Thu Trang; Doan Thi Hong Van; Ta Bich Thuan; Ta Van To; Vuong Dieu Linh; Nguyen Quynh Uyen Journal: Int J Clin Oncol Date: 2015-01-11 Impact factor: 3.402
Authors: Stéphanie Bougel; Stéphanie Renaud; Richard Braunschweig; Dmitri Loukinov; Herbert C Morse; Fred T Bosman; Victor Lobanenkov; Jean Benhattar Journal: J Pathol Date: 2010-01 Impact factor: 7.996
Authors: Stéphanie Renaud; Elena M Pugacheva; M Dolores Delgado; Richard Braunschweig; Ziedulla Abdullaev; Dmitri Loukinov; Jean Benhattar; Victor Lobanenkov Journal: Nucleic Acids Res Date: 2007-10-25 Impact factor: 16.971